INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 415m ago
HOUSE PTR14m ago
SEC 13F14m ago
ROBINHOOD CHAIN14m ago
Corporate insider
LR

Lechleider Robert

Chief Medical OfficerCIK 0001997584

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 5
Max Insider Score33
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$480K
55.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Immunome Inc.Chief Medical Officer · Jun 29, 2026
26
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL
$499K
22.7K sh
Jul 2, 2026
Jul 7, 2026
traded Jul 2, 2026
+5d
SEC FORM 4

Evidence

26
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$369K
16.2K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

30
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$377K
16.1K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

9
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
55.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

17
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$480K
55.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

33
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$794K
40.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

29
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$298K
14.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

3
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
55.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence